王雲章 (1989). 藥用花卉 實用生活叢書.園藝系列. 台北市: 渡假書局.
全中和. (2005). 花蓮區農技報導─苦瓜新品種『花蓮一號』(福寶) (Vol. 63). 花 蓮: 行政院農業委員會花蓮區農業改良場.
沈 靈. (2008). 數種植物性雌激素對動脈硬化相關因子之影響. 國立台灣師範 大學人類發展與家庭學系, 碩士論文
明.李時珍. (1994). 重訂本草綱目. 台北市: 文化圖書公司.
洪雅雯. (2006). 山苦瓜改善高油高糖餵食大鼠腹部體脂堆積及胰島素抗性 中國 醫藥學院醫學研究所碩士論文.
洪永瀚. (2008). 苜蓿芽乙酸乙酯萃取物改善 MRL-lpr/lpr 自體免疫鼠病程發展之 探討. 國立臺灣大學, 博士論文
莊佳穎. (2004). 山苦瓜活化過氧化體增殖劑活化受器 PPARs 之成分分離與鑑 定. 國立台灣大學, 碩士論文
高秋華. (2008). 數種植物性雌激素對代謝症候群之影響. 國立台灣師範大學人 類發展與家庭學系, 碩士論文
陳永如. (2007). 數種植物雌激素食材萃物對 PPAR、脂肪細胞生成及雌激素活性 特質鑑定. 國立台灣大學, 碩士論文.
許婉貞 (2009) 以卵巢剔除小鼠探討數種植物雌激素化合物/萃物之雌激素相關 生理活性 國立台灣大學, 碩士論文.
黃湘儒 (2007) 山苦瓜萃取物對巨噬細胞發炎反應的影響 國立台灣師範大學, 碩士論文.
曾雅旻. (2006). 山苦瓜對 ApoE 剔除鼠脂質代謝的影響. 國立台灣師範大學人類 發展與家庭學系, 碩士論文
趙哲毅. (2003). 苦瓜活化過氧化體增殖劑活化受器及改變脂質代謝相關基因之
表現. 國立臺灣大學, 博士論文
Abd El Sattar El Batran, S., El-Gengaihi, S. E., & El Shabrawy, O. A. (2006). Some toxicological studies of Momordica charantia L. on albino rats in normal and alloxan diabetic rats. J Ethnopharmacol, 108(2), 236-242.
Adlercreutz, H., & Mazur, W. (1997). Phyto-oestrogens and Western diseases. Ann Med, 29(2), 95-120.
Ahmed, I., Lakhani, M. S., Gillett, M., John, A., & Raza, H. (2001).
Hypotriglyceridemic and hypocholesterolemic effects of anti-diabetic
Momordica charantia (karela) fruit extract in streptozotocin-induced diabetic rats. Diabetes Res Clin Pract, 51(3), 155-161.
Arita, Y., Kihara, S., Ouchi, N., Takahashi, M., Maeda, K., Miyagawa, J., et al. (1999).
Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity.
Biochem Biophys Res Commun, 257(1), 79-83.
Asgary, S., Moshtaghian, J., Hosseini, M., & Siadat, H. (2008). Effects of alfalfa on lipoproteins and fatty streak formation in hypercholesterolemic rabbits. Pak J Pharm Sci, 21(4), 460-464.
Asija, A., Peterson, S. J., Stec, D. E., & Abraham, N. G. (2007). Targeting endothelial cells with heme oxygenase-1 gene using VE-cadherin promoter attenuates hyperglycemia-mediated cell injury and apoptosis. Antioxid Redox Signal, 9(12), 2065-2074.
Atta, A. H., & Alkofahi, A. (1998). Anti-nociceptive and anti-inflammatory effects of some Jordanian medicinal plant extracts. J Ethnopharmacol, 60(2), 117-124.
Balla, J., Vercellotti, G. M., Jeney, V., Yachie, A., Varga, Z., Jacob, H. S., et al. (2007).
Heme, heme oxygenase, and ferritin: how the vascular endothelium survives (and dies) in an iron-rich environment. Antioxid Redox Signal, 9(12),
2119-2137.
Beltowski, J. (2003). Adiponectin and resistin--new hormones of white adipose tissue.
Med Sci Monit, 9(2), RA55-61.
Bennett, M. R., Evan, G. I., & Schwartz, S. M. (1995). Apoptosis of human vascular smooth muscle cells derived from normal vessels and coronary atherosclerotic
plaques. J Clin Invest, 95(5), 2266-2274.
Berg, A. H., & Scherer, P. E. (2005). Adipose tissue, inflammation, and cardiovascular disease. Circ Res, 96(9), 939-949.
Biscetti, F., Gaetani, E., Flex, A., Aprahamian, T., Hopkins, T., Straface, G., et al.
(2008). Selective activation of peroxisome proliferator-activated receptor (PPAR)alpha and PPAR gamma induces neoangiogenesis through a vascular endothelial growth factor-dependent mechanism. Diabetes, 57(5), 1394-1404.
Bourgeois, F., Alexiu, A., & Lemonnier, D. (1983). Dietary-induced obesity: effect of dietary fats on adipose tissue cellularity in mice. Br J Nutr, 49(1), 17-26.
Califano, F., Giovanniello, T., Pantone, P., Campana, E., Parlapiano, C., Alegiani, F., et al. (2000). Clinical importance of thrombomodulin serum levels. Eur Rev Med Pharmacol Sci, 4(3), 59-66.
Cerretti, D. P., Kozlosky, C. J., Mosley, B., Nelson, N., Van Ness, K., Greenstreet, T.
A., et al. (1992). Molecular cloning of the interleukin-1 beta converting enzyme. Science, 256(5053), 97-100.
Chao, C. Y., & Huang, C. J. (2003). Bitter gourd (Momordica charantia) extract activates peroxisome proliferator-activated receptors and upregulates the expression of the acyl CoA oxidase gene in H4IIEC3 hepatoma cells. J Biomed Sci, 10(6 Pt 2), 782-791.
Chaput, E., Saladin, R., Silvestre, M., & Edgar, A. D. (2000). Fenofibrate and
rosiglitazone lower serum triglycerides with opposing effects on body weight.
Biochem Biophys Res Commun, 271(2), 445-450.
Chaturvedi, P. (2005). Role of Momordica charantia in maintaining the normal levels of lipids and glucose in diabetic rats fed a high-fat and low-carbohydrate diet.
Br J Biomed Sci, 62(3), 124-126.
Chaturvedi, P., George, S., Milinganyo, M., & Tripathi, Y. B. (2004). Effect of Momordica charantia on lipid profile and oral glucose tolerance in diabetic rats. Phytother Res, 18(11), 954-956.
Chen, J., Muntner, P., Hamm, L. L., Jones, D. W., Batuman, V., Fonseca, V., et al.
(2004). The metabolic syndrome and chronic kidney disease in U.S. adults.
Ann Intern Med, 140(3), 167-174.
Chen, Q., Chan, L. L., & Li, E. T. (2003). Bitter melon (Momordica charantia) reduces adiposity, lowers serum insulin and normalizes glucose tolerance in rats fed a high fat diet. J Nutr, 133(4), 1088-1093.
Choi, J. S., & Song, J. (2009). Effect of genistein on insulin resistance, renal lipid metabolism, and antioxidative activities in ovariectomized rats. Nutrition, 25(6), 676-685.
Clarke, M. C., Figg, N., Maguire, J. J., Davenport, A. P., Goddard, M., Littlewood, T.
D., et al. (2006). Apoptosis of vascular smooth muscle cells induces features of plaque vulnerability in atherosclerosis. Nat Med, 12(9), 1075-1080.
Clarkson, T. B., Anthony, M. S., & Klein, K. P. (1996). Hormone replacement therapy and coronary artery atherosclerosis: the monkey model. Br J Obstet Gynaecol, 103 Suppl 13, 53-57; discussion 57-58.
Combs, T. P., Berg, A. H., Rajala, M. W., Klebanov, S., Iyengar, P., Jimenez-Chillaron, J. C., et al. (2003). Sexual differentiation, pregnancy, calorie restriction, and aging affect the adipocyte-specific secretory protein adiponectin. Diabetes, 52(2), 268-276.
Cornier, M. A., Dabelea, D., Hernandez, T. L., Lindstrom, R. C., Steig, A. J., Stob, N.
R., et al. (2008). The metabolic syndrome. Endocr Rev, 29(7), 777-822.
Cornwell, T., Cohick, W., & Raskin, I. (2004). Dietary phytoestrogens and health.
Phytochemistry, 65(8), 995-1016.
Costet, P., Legendre, C., More, J., Edgar, A., Galtier, P., & Pineau, T. (1998).
Peroxisome proliferator-activated receptor alpha-isoform deficiency leads to progressive dyslipidemia with sexually dimorphic obesity and steatosis. J Biol Chem, 273(45), 29577-29585.
Crawford, S. E., & Borensztajn, J. (1999). Plasma clearance and liver uptake of chylomicron remnants generated by hepatic lipase lipolysis: evidence for a lactoferrin-sensitive and apolipoprotein E-independent pathway. J Lipid Res, 40(5), 797-805.
Day, C., Cartwright, T., Provost, J., & Bailey, C. J. (1990). Hypoglycaemic effect of Momordica charantia extracts. Planta Med, 56(5), 426-429.
de Kleijn, M. J., van der Schouw, Y. T., Wilson, P. W., Grobbee, D. E., & Jacques, P. F.
(2002). Dietary intake of phytoestrogens is associated with a favorable metabolic cardiovascular risk profile in postmenopausal U.S.women: the Framingham study. J Nutr, 132(2), 276-282.
Declercq, V., Yeganeh, B., Moshtaghi-Kashanian, G. R., Khademi, H., Bahadori, B.,
& Moghadasian, M. H. (2005). Paradoxical effects of fenofibrate and nicotinic acid in apo E-deficient mice. J Cardiovasc Pharmacol, 46(1), 18-24.
Dinarello, C. A., & Wolff, S. M. (1993). The role of interleukin-1 in disease. N Engl J Med, 328(2), 106-113.
Dixon, R. A., & Ferreira, D. (2002). Genistein. Phytochemistry, 60(3), 205-211.
Dodge, J. A., Glasebrook, A. L., Magee, D. E., Phillips, D. L., Sato, M., Short, L. L., et al. (1996). Environmental estrogens: effects on cholesterol lowering and bone in the ovariectomized rat. J Steroid Biochem Mol Biol, 59(2), 155-161.
Eberhardt, W., Schulze, M., Engels, C., Klasmeier, E., & Pfeilschifter, J. (2002).
Glucocorticoid-mediated suppression of cytokine-induced matrix
metalloproteinase-9 expression in rat mesangial cells: involvement of nuclear factor-kappaB and Ets transcription factors. Mol Endocrinol, 16(8),
1752-1766.
Eckel, R. H., Grundy, S. M., & Zimmet, P. Z. (2005). The metabolic syndrome.
Lancet, 365(9468), 1415-1428.
Enmark, E., & Gustafsson, J. A. (1999). Oestrogen receptors - an overview. J Intern Med, 246(2), 133-138.
Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). (2001). JAMA, 285(19), 2486-2497.
Falk, E., Shah, P. K., & Fuster, V. (1995). Coronary plaque disruption. Circulation, 92(3), 657-671.
Fernandes, N. P., Lagishetty, C. V., Panda, V. S., & Naik, S. R. (2007). An
experimental evaluation of the antidiabetic and antilipidemic properties of a standardized Momordica charantia fruit extract. BMC Complement Altern Med, 7, 29.
Ford, E. S., & Giles, W. H. (2003). A comparison of the prevalence of the metabolic syndrome using two proposed definitions. Diabetes Care, 26(3), 575-581.
Franke, A. A., Custer, L. J., Cerna, C. M., & Narala, K. (1995). Rapid HPLC analysis of dietary phytoestrogens from legumes and from human urine. Proc Soc Exp Biol Med, 208(1), 18-26.
Fu, T., Kashireddy, P., & Borensztajn, J. (2003). The
peroxisome-proliferator-activated receptor alpha agonist ciprofibrate severely aggravates hypercholesterolaemia and accelerates the development of
atherosclerosis in mice lacking apolipoprotein E. Biochem J, 373(Pt 3), 941-947.
Fujita, T., Toda, K., Karimova, A., Yan, S. F., Naka, Y., Yet, S. F., et al. (2001).
Paradoxical rescue from ischemic lung injury by inhaled carbon monoxide driven by derepression of fibrinolysis. Nat Med, 7(5), 598-604.
Fulop, T., Tessier, D., & Carpentier, A. (2006). The metabolic syndrome. Pathol Biol (Paris), 54(7), 375-386.
Gastaldelli, A., Sironi, A. M., Ciociaro, D., Positano, V., Buzzigoli, E., Giannessi, D., et al. (2005). Visceral fat and beta cell function in non-diabetic humans.
Diabetologia, 48(10), 2090-2096.
Gehm, B. D., McAndrews, J. M., Chien, P. Y., & Jameson, J. L. (1997). Resveratrol, a polyphenolic compound found in grapes and wine, is an agonist for the
estrogen receptor. Proc Natl Acad Sci U S A, 94(25), 14138-14143.
Geng, Y. J., & Libby, P. (1995). Evidence for apoptosis in advanced human atheroma.
Colocalization with interleukin-1 beta-converting enzyme. Am J Pathol, 147(2), 251-266.
Gimeno, R. E., & Klaman, L. D. (2005). Adipose tissue as an active endocrine organ:
recent advances. Curr Opin Pharmacol, 5(2), 122-128.
Glass, C. K., & Witztum, J. L. (2001). Atherosclerosis. the road ahead. Cell, 104(4), 503-516.
Grover, J. K., & Yadav, S. P. (2004). Pharmacological actions and potential uses of Momordica charantia: a review. J Ethnopharmacol, 93(1), 123-132.
Grundy, S. M. (2004). What is the contribution of obesity to the metabolic syndrome?
Endocrinol Metab Clin North Am, 33(2), 267-282, table of contents.
Halvorsen, B., Otterdal, K., Dahl, T. B., Skjelland, M., Gullestad, L., Oie, E., et al.
(2008). Atherosclerotic plaque stability--what determines the fate of a plaque?
Prog Cardiovasc Dis, 51(3), 183-194.
Hamilton, B. S., Paglia, D., Kwan, A. Y., & Deitel, M. (1995). Increased obese mRNA expression in omental fat cells from massively obese humans. Nat Med, 1(9), 953-956.
Hamosh, M., & Hamosh, P. (1975). The effect of estrogen on the lipoprotein lipase activity of rat adipose tissue. J Clin Invest, 55(5), 1132-1135.
Harmon, A. W., & Harp, J. B. (2001). Differential effects of flavonoids on 3T3-L1 adipogenesis and lipolysis. Am J Physiol Cell Physiol, 280(4), C807-813.
Hirose, N., Inoue, T., Nishihara, K., Sugano, M., Akimoto, K., Shimizu, S., et al.
(1991). Inhibition of cholesterol absorption and synthesis in rats by sesamin. J Lipid Res, 32(4), 629-638.
Hodgson, J. M., Puddey, I. B., Beilin, L. J., Mori, T. A., & Croft, K. D. (1998).
Supplementation with isoflavonoid phytoestrogens does not alter serum lipid concentrations: a randomized controlled trial in humans. J Nutr, 128(4), 728-732.
Hotta, K., Funahashi, T., Arita, Y., Takahashi, M., Matsuda, M., Okamoto, Y., et al.
(2000). Plasma concentrations of a novel, adipose-specific protein,
adiponectin, in type 2 diabetic patients. Arterioscler Thromb Vasc Biol, 20(6), 1595-1599.
Houseknecht, K. L., Baile, C. A., Matteri, R. L., & Spurlock, M. E. (1998). The biology of leptin: a review. J Anim Sci, 76(5), 1405-1420.
Idriss, N. K., Blann, A. D., & Lip, G. Y. (2008). Hemoxygenase-1 in cardiovascular disease. J Am Coll Cardiol, 52(12), 971-978.
Iida, S., & Komiyama, N. (2009). Balance between interleukin-1beta and
interleukin-1 receptor antagonist in the development of atherosclerosis. A
polymorphism in the interleukin-1 receptor antagonist. Circ J, 73(8), 1401-1402.
Iritani, N., Sugimoto, T., Fukuda, H., Komiya, M., & Ikeda, H. (1997). Dietary soybean protein increases insulin receptor gene expression in Wistar fatty rats when dietary polyunsaturated fatty acid level is low. J Nutr, 127(6),
1077-1083.
Jayasooriya, A. P., Sakono, M., Yukizaki, C., Kawano, M., Yamamoto, K., & Fukuda, N. (2000). Effects of Momordica charantia powder on serum glucose levels and various lipid parameters in rats fed with cholesterol-free and
cholesterol-enriched diets. J Ethnopharmacol, 72(1-2), 331-336.
Jiang, T., Wang, Z., Proctor, G., Moskowitz, S., Liebman, S. E., Rogers, T., et al.
(2005). Diet-induced obesity in C57BL/6J mice causes increased renal lipid accumulation and glomerulosclerosis via a sterol regulatory element-binding protein-1c-dependent pathway. J Biol Chem, 280(37), 32317-32325.
Jurimae, J., & Jurimae, T. (2007). Plasma adiponectin concentration in healthy pre- and postmenopausal women: relationship with body composition, bone mineral, and metabolic variables. Am J Physiol Endocrinol Metab, 293(1), E42-47.
Kahn, B. B., & Flier, J. S. (2000). Obesity and insulin resistance. J Clin Invest, 106(4), 473-481.
Kai, H., Ikeda, H., Yasukawa, H., Kai, M., Seki, Y., Kuwahara, F., et al. (1998).
Peripheral blood levels of matrix metalloproteases-2 and -9 are elevated in patients with acute coronary syndromes. J Am Coll Cardiol, 32(2), 368-372.
Khanna, P., Jain, S. C., Panagariya, A., & Dixit, V. P. (1981). Hypoglycemic activity of polypeptide-p from a plant source. J Nat Prod, 44(6), 648-655.
Kimmelstiel, P., & Wilson, C. (1936). Intercapillary Lesions in the Glomeruli of the Kidney. Am J Pathol, 12(1), 83-98 87.
Kirii, H., Niwa, T., Yamada, Y., Wada, H., Saito, K., Iwakura, Y., et al. (2003). Lack of interleukin-1beta decreases the severity of atherosclerosis in ApoE-deficient mice. Arterioscler Thromb Vasc Biol, 23(4), 656-660.
Knight, D. C., & Eden, J. A. (1996). A review of the clinical effects of phytoestrogens.
Obstet Gynecol, 87(5 Pt 2), 897-904.
Knuckles, B. E., deFremery, D., & Kohler, G. O. (1976). Coumestrol content of fractions obtained during wet processing of alfalfa. J Agric Food Chem, 24(6), 1177-1180.
Kobori, M., Nakayama, H., Fukushima, K., Ohnishi-Kameyama, M., Ono, H., Fukushima, T., et al. (2008). Bitter gourd suppresses
lipopolysaccharide-induced inflammatory responses. J Agric Food Chem,
56(11), 4004-4011.
Kolanjiappan, K., & Manoharan, S. (2005). Chemopreventive efficacy and anti-lipid peroxidative potential of Jasminum grandiflorum Linn. on
7,12-dimethylbenz(a)anthracene-induced rat mammary carcinogenesis.
Fundam Clin Pharmacol, 19(6), 687-693.
Kubota, N., Terauchi, Y., Yamauchi, T., Kubota, T., Moroi, M., Matsui, J., et al. (2002).
Disruption of adiponectin causes insulin resistance and neointimal formation.
J Biol Chem, 277(29), 25863-25866.
Kuiper, G. G., Lemmen, J. G., Carlsson, B., Corton, J. C., Safe, S. H., van der Saag, P.
T., et al. (1998). Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta. Endocrinology, 139(10), 4252-4263.
Kunte, H., Amberger, N., Busch, M. A., Ruckert, R. I., Meiners, S., & Harms, L.
(2008). Markers of instability in high-risk carotid plaques are reduced by statins. J Vasc Surg, 47(3), 513-522.
Landolfi, R., Mower, R. L., & Steiner, M. (1984). Modification of platelet function and arachidonic acid metabolism by bioflavonoids. Structure-activity relations.
Biochem Pharmacol, 33(9), 1525-1530.
Lara-Castro, C., Fu, Y., Chung, B. H., & Garvey, W. T. (2007). Adiponectin and the metabolic syndrome: mechanisms mediating risk for metabolic and
cardiovascular disease. Curr Opin Lipidol, 18(3), 263-270.
Lau, D. C., Dhillon, B., Yan, H., Szmitko, P. E., & Verma, S. (2005). Adipokines:
molecular links between obesity and atheroslcerosis. Am J Physiol Heart Circ Physiol, 288(5), H2031-2041.
Lee, I. S., Shin, G., & Choue, R. (2009). Shifts in Diet from High Fat to High Carbohydrate Improved Levels of Adipokines and Pro-inflammatory Cytokines in Mice Fed a High-fat Diet. Endocr J.
Lemieux, C., Picard, F., Labrie, F., Richard, D., & Deshaies, Y. (2003). The estrogen antagonist EM-652 and dehydroepiandrosterone prevent diet- and
ovariectomy-induced obesity. Obes Res, 11(3), 477-490.
Li, A. C., & Glass, C. K. (2004). PPAR- and LXR-dependent pathways controlling lipid metabolism and the development of atherosclerosis. J Lipid Res, 45(12), 2161-2173.
Li, C. J., Sun, H. W., Zhu, F. L., Chen, L., Rong, Y. Y., Zhang, Y., et al. (2007). Local adiponectin treatment reduces atherosclerotic plaque size in rabbits. J
Endocrinol, 193(1), 137-145.
Liang, C. P., & Tall, A. R. (2001). Transcriptional profiling reveals global defects in energy metabolism, lipoprotein, and bile acid synthesis and transport with reversal by leptin treatment in ob/ob mouse liver. J Biol Chem, 276(52),
49066-49076.
Liapis, C. D., Avgerinos, E. D., Kadoglou, N. P., & Kakisis, J. D. (2009). What a vascular surgeon should know and do about atherosclerotic risk factors. J Vasc Surg, 49(5), 1348-1354.
Lii, C. K., Chen, H. W., Yun, W. T., & Liu, K. L. (2009). Suppressive effects of wild bitter gourd (Momordica charantia Linn. var. abbreviata ser.) fruit extracts on inflammatory responses in RAW264.7 macrophages. J Ethnopharmacol, 122(2), 227-233.
Lin, C. H., Chou, C. Y., Lin, C. C., Huang, C. C., Liu, C. S., & Lai, S. W. (2007).
Waist-to-height ratio is the best index of obesity in association with chronic kidney disease. Nutrition, 23(11-12), 788-793.
Lin, S. J., Lee, I. T., Chen, Y. H., Lin, F. Y., Sheu, L. M., Ku, H. H., et al. (2007).
Salvianolic acid B attenuates MMP-2 and MMP-9 expression in vivo in apolipoprotein-E-deficient mouse aorta and in vitro in LPS-treated human aortic smooth muscle cells. J Cell Biochem, 100(2), 372-384.
Liu, X. M., Chapman, G. B., Peyton, K. J., Schafer, A. I., & Durante, W. (2002).
Carbon monoxide inhibits apoptosis in vascular smooth muscle cells.
Cardiovasc Res, 55(2), 396-405.
Loftus, I. M., Naylor, A. R., Goodall, S., Crowther, M., Jones, L., Bell, P. R., et al.
(2000). Increased matrix metalloproteinase-9 activity in unstable carotid plaques. A potential role in acute plaque disruption. Stroke, 31(1), 40-47.
Luttun, A., Lutgens, E., Manderveld, A., Maris, K., Collen, D., Carmeliet, P., et al.
(2004). Loss of matrix metalloproteinase-9 or matrix metalloproteinase-12 protects apolipoprotein E-deficient mice against atherosclerotic media destruction but differentially affects plaque growth. Circulation, 109(11), 1408-1414.
Mardones, P., Pilon, A., Bouly, M., Duran, D., Nishimoto, T., Arai, H., et al. (2003).
Fibrates down-regulate hepatic scavenger receptor class B type I protein expression in mice. J Biol Chem, 278(10), 7884-7890.
Matsuda, H., Li, Y., Murakami, T., Matsumura, N., Yamahara, J., & Yoshikawa, M.
(1998). Antidiabetic principles of natural medicines. III. Structure-related inhibitory activity and action mode of oleanolic acid glycosides on hypoglycemic activity. Chem Pharm Bull (Tokyo), 46(9), 1399-1403.
Mazur, W. M., Wahala, K., Rasku, S., Salakka, A., Hase, T., & Adlercreutz, H. (1998).
Lignan and isoflavonoid concentrations in tea and coffee. Br J Nutr, 79(1), 37-45.
Meir, K. S., & Leitersdorf, E. (2004). Atherosclerosis in the
apolipoprotein-E-deficient mouse: a decade of progress. Arterioscler Thromb
Vasc Biol, 24(6), 1006-1014.
Miura, T., Itoh, C., Iwamoto, N., Kato, M., Kawai, M., Park, S. R., et al. (2001).
Hypoglycemic activity of the fruit of the Momordica charantia in type 2 diabetic mice. J Nutr Sci Vitaminol (Tokyo), 47(5), 340-344.
Morita, T., & Kourembanas, S. (1995). Endothelial cell expression of vasoconstrictors and growth factors is regulated by smooth muscle cell-derived carbon
monoxide. J Clin Invest, 96(6), 2676-2682.
Muoio, D. M., & Lynis Dohm, G. (2002). Peripheral metabolic actions of leptin. Best Pract Res Clin Endocrinol Metab, 16(4), 653-666.
Murray, C. J., & Lopez, A. D. (1997). Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study. Lancet, 349(9063),
1436-1442.
Naaz, A., Yellayi, S., Zakroczymski, M. A., Bunick, D., Doerge, D. R., Lubahn, D. B., et al. (2003). The soy isoflavone genistein decreases adipose deposition in mice. Endocrinology, 144(8), 3315-3320.
Nachman, R. L., Hajjar, K. A., Silverstein, R. L., & Dinarello, C. A. (1986).
Interleukin 1 induces endothelial cell synthesis of plasminogen activator inhibitor. J Exp Med, 163(6), 1595-1600.
Nakashima, Y., Plump, A. S., Raines, E. W., Breslow, J. L., & Ross, R. (1994).
ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree. Arterioscler Thromb, 14(1), 133-140.
Nerurkar, P. V., Pearson, L., Efird, J. T., Adeli, K., Theriault, A. G., & Nerurkar, V. R.
(2005). Microsomal triglyceride transfer protein gene expression and ApoB secretion are inhibited by bitter melon in HepG2 cells. J Nutr, 135(4), 702-706.
Nestel, P. J., Yamashita, T., Sasahara, T., Pomeroy, S., Dart, A., Komesaroff, P., et al.
(1997). Soy isoflavones improve systemic arterial compliance but not plasma lipids in menopausal and perimenopausal women. Arterioscler Thromb Vasc Biol, 17(12), 3392-3398.
Neuzil, J., & Stocker, R. (1994). Free and albumin-bound bilirubin are efficient co-antioxidants for alpha-tocopherol, inhibiting plasma and low density lipoprotein lipid peroxidation. J Biol Chem, 269(24), 16712-16719.
Nogowski, L., Nowak, K. W., & Mackowiak, P. (1992). Effect of
phytooestrogen--coumestrol and oestrone on some aspects of carbohydrate metabolism in ovariectomized female rats. Arch Vet Pol, 32(3-4), 79-84.
Noguchi, R., Yasui, Y., Suzuki, R., Hosokawa, M., Fukunaga, K., & Miyashita, K.
(2001). Dietary effects of bitter gourd oil on blood and liver lipids of rats. Arch Biochem Biophys, 396(2), 207-212.
Oak, M. H., El Bedoui, J., & Schini-Kerth, V. B. (2005). Antiangiogenic properties of natural polyphenols from red wine and green tea. J Nutr Biochem, 16(1), 1-8.
Otabe, S., Yuan, X., Fukutani, T., Wada, N., Hashinaga, T., Nakayama, H., et al.
(2007). Overexpression of human adiponectin in transgenic mice results in suppression of fat accumulation and prevention of premature death by high-calorie diet. Am J Physiol Endocrinol Metab, 293(1), E210-218.
Ouchi, N., Kihara, S., Arita, Y., Maeda, K., Kuriyama, H., Okamoto, Y., et al. (1999).
Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin. Circulation, 100(25), 2473-2476.
Park, E. J., & Pezzuto, J. M. (2002). Botanicals in cancer chemoprevention. Cancer Metastasis Rev, 21(3-4), 231-255.
Peluso, M. R. (2006). Flavonoids attenuate cardiovascular disease, inhibit
phosphodiesterase, and modulate lipid homeostasis in adipose tissue and liver.
Exp Biol Med (Maywood), 231(8), 1287-1299.
Piedrahita, J. A., Zhang, S. H., Hagaman, J. R., Oliver, P. M., & Maeda, N. (1992).
Generation of mice carrying a mutant apolipoprotein E gene inactivated by gene targeting in embryonic stem cells. Proc Natl Acad Sci U S A, 89(10), 4471-4475.
Pischon, T., Girman, C. J., Hotamisligil, G. S., Rifai, N., Hu, F. B., & Rimm, E. B.
(2004). Plasma adiponectin levels and risk of myocardial infarction in men.
JAMA, 291(14), 1730-1737.
Ponka, P. (1999). Cell biology of heme. Am J Med Sci, 318(4), 241-256.
Rathi, S. S., Grover, J. K., Vikrant, V., & Biswas, N. R. (2002). Prevention of experimental diabetic cataract by Indian Ayurvedic plant extracts. Phytother Res, 16(8), 774-777.
Rodriguez, J. A., Orbe, J., & Paramo, J. A. (2007). [Metalloproteases, vascular remodeling and atherothrombotic syndromes]. Rev Esp Cardiol, 60(9), 959-967.
Rosenfeld, M. E., Polinsky, P., Virmani, R., Kauser, K., Rubanyi, G., & Schwartz, S.
M. (2000). Advanced atherosclerotic lesions in the innominate artery of the ApoE knockout mouse. Arterioscler Thromb Vasc Biol, 20(12), 2587-2592.
Ross, R. (1999). Atherosclerosis--an inflammatory disease. N Engl J Med, 340(2), 115-126.
Ruggeri, Z. M. (2002). Platelets in atherothrombosis. Nat Med, 8(11), 1227-1234.
Rushworth, S. A., & MacEwan, D. J. (2008). HO-1 underlies resistance of AML cells to TNF-induced apoptosis. Blood, 111(7), 3793-3801.
Samman, S., Lyons Wall, P. M., Chan, G. S., Smith, S. J., & Petocz, P. (1999). The effect of supplementation with isoflavones on plasma lipids and oxidisability
of low density lipoprotein in premenopausal women. Atherosclerosis, 147(2), 277-283.
Sargeant, P., Farndale, R. W., & Sage, S. O. (1993). The tyrosine kinase inhibitors methyl 2,5-dihydroxycinnamate and genistein reduce thrombin-evoked tyrosine phosphorylation and Ca2+ entry in human platelets. FEBS Lett, 315(3), 242-246.
Sass, G., Shembade, N. D., & Tiegs, G. (2005). Tumour necrosis factor alpha (TNF)-TNF receptor 1-inducible cytoprotective proteins in the mouse liver:
relevance of suppressors of cytokine signalling. Biochem J, 385(Pt 2), 537-544.
Sayegh, R. A., Kelly, L., Wurtman, J., Deitch, A., & Chelmow, D. (1999). Impact of hormone replacement therapy on the body mass and fat compositions of menopausal women: a cross-sectional study. Menopause, 6(4), 312-315.
Schaub, F. J., Han, D. K., Liles, W. C., Adams, L. D., Coats, S. A., Ramachandran, R.
K., et al. (2000). Fas/FADD-mediated activation of a specific program of inflammatory gene expression in vascular smooth muscle cells. Nat Med, 6(7),
K., et al. (2000). Fas/FADD-mediated activation of a specific program of inflammatory gene expression in vascular smooth muscle cells. Nat Med, 6(7),